Subthreshold Micropulse Laser Treatment of Acute Central Serous Chorioretinopathy

Minia University

Status: Completed

Conditions: Acute Central Serous Retinopathy With Subretinal Fluid

Treatments: Procedure: Micropulse laser

Study type: Interventional

Funder types: Other

Identifiers

NCT05447117

CSCR2019

Details and patient eligibility

About

To evaluate the efficacy and safety of 532 nm green subthreshold micropulse laser (GSML) as a treatment for acute central serous chorioretinopathy (CSCR).

Full description

This prospective study included 42 eyes of 42 patients with acute CSCR treated with IRIDEX™ IQ 532 nm GSML. The study was conducted at Minia University Hospital and Genaidy Ophthalmology Center, Minia, Egypt between October 2019 and May 2022. All patients were subjected to a complete ophthalmological examination, fluorescein angiography (FA) and optical coherence tomography (OCT) at baseline and each follow-up visit 1, 3 and 18 months after laser treatment

Enrollment: 42 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• acute CSCR

Exclusion criteria

• chronic CSCR Previously treated case of Acute CSCR

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)